Treatment of depression in HIV positive individuals: a critical review (Q37073668)

18 August 2017

1 reference

title

Treatment of depression in HIV positive individuals: a critical review (English)

1 reference

18 August 2017

0 references

2

Zachary Freyberg

1 reference

18 August 2017

1

Stephen J Ferrando

1 reference

18 August 2017

1 February 2008

1 reference

International Review of Psychiatry

18 August 2017

1 reference

18 August 2017

20

1 reference

18 August 2017

1

1 reference

18 August 2017

61-71

1 reference

Predictors of nonadherence to HIV-related medication regimens during methadone stabilization

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-Positive gay men treated with HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Mirtazapine for depression in patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Clinical management of psychiatric disorders in patients with HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/EST women's project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Treatment of depressive symptoms in human immunodeficiency virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Psychological effects of HAART: a 2-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Double-blind comparison of fluoxetine and desipramine in the treatment of depressed women with advanced HIV disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

Structured group therapy and fluoxetine to treat depression in HIV-positive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701862060

10.1080/09540260701862060

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18240063